Take Our PhysQuiz on ACR Convergence 2020!
Test your knowledge on results on PsA released at ACR Convergence 2020 – take our quiz and...
Read MoreMar 19, 2021
Test your knowledge on results on PsA released at ACR Convergence 2020 – take our quiz and...
Read MoreMar 13, 2021
Test your knowledge on SABCS 2020 – take our quiz and see how you compare with your...
Read MoreJan 25, 2021
[flippingbook width=”100%” height=”auto” ratio=”3:2″ title=”Verzenio – MonarchE”]https://online.flippingbook.com/view/449874131/[/flippingbook] In an extended analysis of the...
Read MoreJan 25, 2021
Certain patients with luminal early breast cancer and up to 3 involved lymph nodes can be treated with adjuvant endocrine therapy alone, according to the primary outcome analysis of the ADAPT HR+/HER2- trial (NCT01779206),...
Read MoreJan 1, 2021
In an interim analysis of the first immunotherapy combination phase 1b trial with trastuzumab deruxtecan, safety results showed nivolumab with trastuzumab deruxtecan was well tolerated in patients with HER2-positive or HER2-low...
Read MoreDec 30, 2020
In an updated analysis of the phase 2 DESTINY-Breast01 study, women with HER2-positive metastatic breast cancer taking antibody-drug conjugate trastuzumab deruxtecan continued to demonstrate favorable efficacy data, durable...
Read MoreDec 18, 2020
Acute side-effects of radiation therapy (RT) are often underrecognized by the physicians of...
Read MoreDec 18, 2020
An online tool (RSClin) incorporating clinical-pathologic data and results of the 21-gene...
Read MoreDec 18, 2020
Meeting Brief… A subgroup of patients participating in the randomized phase III NALA study...
Read MoreDec 18, 2020
The omission of radiotherapy (RT) does not affect overall survival at 10 years after breast...
Read MoreDec 18, 2020
Pregnancy is less likely after prior breast cancer (BC) diagnosis, according to a systematic...
Read MoreDec 15, 2020
MONDAY, Dec. 14, 2020 (HealthDay News) — Pregnancy is less likely after prior breast cancer...
Read MoreDec 4, 2020
The results of CONTESSA, a Phase 3 study of tesetaxel in the treatment of patients with metastatic breast cancer, have been selected for an oral presentation at the 2020 SABCS, to be held virtually December 8-11, 2020. The...
Read MoreDec 4, 2020
Homologous recombination deficiency represents a new therapeutic strategy for breast cancer brain metastases Nicola S Cosgrove BACKGROUND: Brain metastatic disease occurs in 10-30% of metastatic breast cancer cases. The...
Read MoreDec 4, 2020
The collaborative Phase 3 PENELOPE-B will be presented at SABCS 2020. No unexpected safety signals were observed. Phase 3 PENELOPE-B trial did not meet the primary endpoint of improved invasive disease-free survival (iDFS) in...
Read MoreDec 4, 2020
New Data for HER2 and HER3 Directed DXd ADCs at SABCS includes longer follow-up research data for ENHERTU® based on DESTINY-Breast01, including updated duration of response, progression-free survival, an 18-month landmark...
Read MoreDec 4, 2020
The 43rd Virtual San Antonio Breast Cancer Symposium (SABCS®) will take place from December 8-11, 2020. The SABCS is the premier conference for basic, translational, and clinical cancer research professionals. It is well-known...
Read MoreSep 19, 2020
Thank you for taking our quiz on PsA from results presented at ACR Convergence 2020! How did you do? 1) DMARD-naïve patients achieving Routine Assessment of Patient Index Data 3 (RAPID3) and the Clinical Disease Activity for...
Read More